The uproar over the 5,000-percent increase for a drug called Daraprizm has been insightful. First a professor of pharmacy at Ohio Northern says a “market solution” will lower the price, along with competition. Maybe it will only be $300 or $400 then, but this is his idea of the “free market” at work.